However, the loss clock we defined is quantifying methylation loss in low CpG content sites rather than the ageing clock’s methylation gain in CpG islands, and in both tumors and normal breast tissues, the loss signature is not correlated to patient age and may represent tumor cell replicative age instead. This evidence concerns the gene CLOCK and neoplasm.